MAGI2 and breast carcinoma: Previous studies have also shown that miR-27a-3p can target and negatively regulate MAGI2, which inactivates the PI3K/AKT signalling pathway by upregulating PTEN and downregulating PD-L1, thereby promoting immune evasion in breast cancer cells (53).